Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

• Egile Nagusiak: Andrea Miró-Canturri (Egilea), Rafael Ayerbe-Algaba (Egilea), Andrea Vila-Domínguez (Egilea), Manuel E. Jiménez-Mejías (Egilea), Jerónimo Pachón (Egilea), Younes Smani (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The development of new strategic antimicrobial therapeutic approaches, such as drug repurposing, has become an urgent need. Previously, we reported that tamoxifen presents therapeutic efficacy against multidrug-resistant (MDR) <i>Acinetobacter baumannii</i>, <i>Pseudomonas aerugino...